事業提携・ライセンシング・投資・M&A動向:April 2013(製薬業界)...市場調査レポートについてご紹介

【英文タイトル】Partnerships, Licensing, Investments and M&A Deals and Trends for April 2013 in Pharmaceuticals

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Pharmaceuticals & Healthcare, Global, Deal Summary, 7
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, April 2013 7
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, April 2013 9
2.2.1 Thermo Fisher Scientific to Acquire Life Technologies for US$13.6 Billion 9
2.2.2 Sanofi Completes Public Offering of Notes Due 2018 for US$1.5 Billion 10
2.2.3 Bayer to Acquire Conceptus, Contraceptive Devices Maker for US$1.1 Billion 10
2.2.4 Roper Industries Completes Acquisition of Managed Health Care Associates for US$1 Billion 10
2.2.5 Covidien Prices Private Placement of Notes for US$900 Million 10
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, April 2013 11
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, April 2013 12
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 13
3.1 Pharmaceuticals & Healthcare, Global, M&A, April 2013 13
3.1.1 Top M&A Deals in April 2013 14
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, November 2012–April 2013 15
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, April 2013 16
3.2.1 Top Equity Offering Deals in April 2013 17
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, November 2012– April 2013 18
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, April 2013 19
3.3.1 Top PE/VC Deals in April 2013 20
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, April 2013 21
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, April 2013 22
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, November 2012– April 2013 24
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, November 2012–April 2013 25
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, April 2013 26
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, April 2013 26
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, November 2012– April 2013 27
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), April 2013 28
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, April 2013 29
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), November 2012– April 2013 30
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, November 2012– April 2013 31
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), November 2012– April 2013 32
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), November 2012– April 2013 33
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, April 2013 34
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, April 2013 34
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), April 2013 35
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, April 2013 36
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, April 2013 36
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, April 2013 36
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), November 2012– April 2013 37
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), November 2012 – April 2013 38
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), November 2012 – April 2013 39
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), November 2012– April 2013 41
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 42
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, April 2013 42
6.1.1 Oncology – Deals of the Month 43
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, April 2013 45
6.2.1 Central Nervous System – Deals of the Month 46
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, April 2013 47
6.3.1 Infectious Diseases – Deals of the Month 48
6.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, April 2013 49
6.4.1 Cardiovascular – Deal of the Month 50
6.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, April 2013 51
6.5.1 Metabolic Disorders – Deal of the Month 52
6.6 Pharmaceuticals & Healthcare, Global, Immunology Deals, April 2013 53
6.6.1 Immunology – Deal of the Month 54
6.7 Pharmaceuticals & Healthcare, Global, Respiratory, Deals, April 2013 55
6.7.1 Respiratory – Deal of the Month 56
7 Deal Summary by Geography 57
7.1 Pharmaceuticals & Healthcare, North America Deals, April 2013 57
7.1.1 North America – Deals of the Month 58
7.2 Pharmaceuticals & Healthcare, Europe, Deals, April 2013 59
7.2.1 Europe – Deals of the Month 60
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, April 2013 61
7.3.1 Asia-Pacific – Deals of the Month 62
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, April 2013 63
7.4.1 Rest of the World – Deals of the Month 64
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 65
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, November 2012 – April 2013 65
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, November 2012 – April 2013 66
9 Further Information 67
9.1 Methodology 67
9.2 About GlobalData 68
9.3 Contact Us 68
9.4 Disclosure information 68
9.5 Disclaimer 68


【レポート販売概要】

■ タイトル:事業提携・ライセンシング・投資・M&A動向:April 2013(製薬業界)
■ 英文:Partnerships, Licensing, Investments and M&A Deals and Trends for April 2013 in Pharmaceuticals
■ 発行日:2013年5月15日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160949
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。